Total planned funding: $177,072,142
Allocations
Countries/Regions
India | $177,072,142 |
Organizational Types
Unknown | $63,295,036 |
NGO | $56,610,170 |
Own Agency | $28,569,052 |
University | $15,532,112 |
Private Contractor | $3,339,272 |
Implementing Agency | $3,100,000 |
Multi-lateral Agency | $2,860,000 |
FBO | $1,600,000 |
Host Country Government Agency | $1,539,200 |
Other USG Agency | $627,300 |
Program Areas
Governance and Systems | $72,347,553 |
Prevention | $43,121,634 |
Care | $22,209,419 |
Management and Operations | $21,213,731 |
Testing | $9,607,636 |
Treatment | $8,572,169 |
Budget Codes
OHSS: Health Systems Strengthening | $41,934,462 |
HVSI: Strategic Information | $24,995,949 |
HVOP: Sexual Prevention: Other Sexual Prevention | $24,765,438 |
HVMS: Management and Operations | $21,213,731 |
HBHC: Care: Adult Care and Support | $13,128,057 |
HVCT: Testing: HIV Testing and Counseling | $9,607,636 |
HTXS: Treatment: Adult Treatment | $8,018,674 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $7,866,014 |
HLAB: Laboratory Infrastructure | $5,417,142 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $5,375,472 |
HKID: Care: Orphans and Vulnerable Children | $4,762,992 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $3,805,057 |
HVTB: Care: TB/HIV | $3,495,030 |
HMBL: Biomedical Prevention: Blood Safety | $1,299,653 |
PDCS: Care: Pediatric Care and Support | $823,340 |
PDTX: Treatment: Pediatric Treatment | $530,018 |
HTXD: Treatment: ARV Drugs | $23,477 |
HMIN: Biomedical Prevention: Injection Safety | $10,000 |
Top Partner Programs
Not Available:
$62,670,547
Countries/Regions
FHI 360:
$18,429,182
Countries/Regions
USG Aggregated Agencies:
$18,000,985
Countries/Regions
Voluntary Health Services:
$11,460,000
Countries/Regions